ATLANTA, Oct. 25, 2010 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq:ALIM) (“Alimera”), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it will release its third quarter 2010 financial results after the market close on Thursday, November 4, 2010. An investor conference call will follow on the same day at 4:30 p.m. ET.
